Mark Fiala, MSW, PhD

Academic Department Internal Medicine
Research Program Hematopoietic Development & Malignancy
Mark Fiala

Researcher Background

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, WashU Medicine

Education

  • 2017: MSW, Health Concentration, WashU Medicine, St. Louis, MO
  • 2022: PhD of Social Work, Saint Louis University, St. Louis, MO

Research & Select Publications

Research Interest

Understanding and elimination of cancer disparities. I am interested in how social determinants of health, such as race, socioeconomic status, and insurance coverage, impact what treatment patients with cancer receive and their health outcomes. My goal is to improve the care of underserved communities by recognizing the factors that are associated with inferior treatments and outcomes and developing interventions to eliminate the disparities. In addition, I collaborate on numerous studies involving cancer epidemiology, biomarkers, and treatments.

Research Publications

A Call for Compassion: How You Can Help Get Multiple Myeloma Added to the Social Security Administration's Compassionate Allowances List.
Authors:

Mehta A, Kaczynski M, Addison S, Slade MJ, Fiala MA

Journal & Year:

Clin Lymphoma Myeloma Leuk • 2026

Financial Toxicity and Satisfaction With Cancer Treatment Among Patients With Multiple Myeloma: An Analysis of the MMRF's CureCloud Initiative.
Authors:

Fiala MA, Lepisto E, Amadi-Mgbenka C, one or more additional authors omitted Cho HJ

Journal & Year:

Clin Lymphoma Myeloma Leuk • 2026

A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.
Authors:

Pilcher WC, Yao L, Gonzalez-Kozlova E, one or more additional authors omitted Fiala MA, one or more additional authors omitted Bhasin M

Journal & Year:

Nat Cancer • 2026

High-Deductible Health Plans and Out-of-Pocket Health Care Costs Among Younger Patients With Multiple Myeloma.
Authors:

Fiala MA, Ji M, Slade M, one or more additional authors omitted Chang SH

Journal & Year:

JCO Oncol Pract • 2026

Perceived Discrimination in the Healthcare Setting and Medical Mistrust: Findings from the Health Information National Trends Survey, 2022.
Authors:

Kaczynski MA, Benitez G, Shehadeh F, Mylonakis E, Fiala MA

Journal & Year:

J Gen Intern Med • 2025

Disparities in Access and Utilization of Electronic Health Record Patient Portals.
Authors:

Shah A, Fiala MA

Journal & Year:

J Gen Intern Med • 2025

Returning to work after breast cancer: a longitudinal analysis of employment and financial hardship.
Authors:

Park E, Peterson L, McKeon S, Fiala MA

Journal & Year:

Breast Cancer Res Treat • 2025

Disparities in electronic health record patient portal activation and use among people with hematological malignancies.
Authors:

Trammel AM, Sisk BA, Fiala MA

Journal & Year:

J Geriatr Oncol • 2025

Treatment Access among Younger Medicaid Beneficiaries with Multiple Myeloma.
Authors:

Fiala MA, Ji M, Shih YH, one or more additional authors omitted Chang SH

Journal & Year:

Clin Lymphoma Myeloma Leuk • 2025

Convenience Versus Continuity: A Pilot Study of Care Transfer to a Satellite Clinic for Patients With Plasma Cell Dyscrasias.
Authors:

Vickroy AM, Kavanaugh M, Smith J, one or more additional authors omitted Fiala MA

Journal & Year:

Cancer Control • 2025

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma.
Authors:

Sun J, Corradini S, Azab F, one or more additional authors omitted Fiala M, one or more additional authors omitted Azab AK

Journal & Year:

Leukemia • 2024

Financial Toxicity and Willingness-to-Pay for Cancer Treatment Among People With Multiple Myeloma.
Authors:

Fiala MA

Journal & Year:

JCO Oncol Pract • 2024

Mixed-Methods Study on the Responsiveness of the Comprehensive Score for Financial Toxicity Among People With Multiple Myeloma.
Authors:

Fiala MA, Leblanc MR, Coccia KW, one or more additional authors omitted Vij R

Journal & Year:

JCO Oncol Pract • 2024